Article
Pembrolizumab combined with Axitinib in ASPSCR1-TFE3 gene fusion translocation renal cell carcinoma: a case report and literature review
2022-10-06
Abstract excerpt
<h4>Background: </h4> Translocation renal cell carcinoma (tRCC) is a subtype of nccRCC driven by MiT/TFE gene fusion. The demographic characteristics of tRCC include younger age at diagnosis, later staging at diagnosis, high degree of malignancy, poor prognosis, and female majority. There are currently no standard guidelines for the diagnosis and treatment of this type of kidney cancer. <h4>Objective:</h4> To inve...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e6bcc509-4680-5966-ab57-99bf6d4b3a3a
- DOI
- 10.21203/rs.3.rs-2101971/v1
